Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Warren Urges Government to Seize Patents on Pfizer’s Cancer Drug

Feb. 18, 2022, 9:53 PM

Pfizer Inc.‘s prostate cancer medicine Xtandi is in the crosshairs of a growing campaign for the government to seize patent rights to bolster competition.

Sen. Elizabeth Warren (D-Mass.) and two other lawmakers are pushing the Biden administration to take unilateral action to lower the price of the drug, pointing to a decades-old law that lets the government leverage “march-in rights” to license patents on certain medicines to outside manufacturers.

“We urge you to use existing executive authority to deliver meaningful relief to consumers,” Warren wrote in a Thursday letter to Health and Human Services Secretary Xavier Becerra. Doing so ...